J4

• 临床研究 • 上一篇    下一篇

西洋参叶三醇组皂苷对乳腺癌放疗患者外周血免疫球蛋白、补体水平及淋巴细胞CD4、CD8和CD25表达的影响

王春刚1,2, 贾晓晶1,3,董丽华1,3,吴镇凤1,龚守良3*,马兴元4, 陈燕萍4   

  1. 1. 吉林大学第二医院放疗科,吉林 长春130041;2. 解放军第208医院放疗科,吉林 长春130062;3. 吉林大学公共卫生学院卫生部放射生物学重点实验室,吉林 长春130021;4. 吉林大学化学学院教学中心,吉林 长春130021
  • 收稿日期:2002-11-23 修回日期:1900-01-01 出版日期:2005-03-28 发布日期:2005-03-28
  • 通讯作者: 龚守良

Effects of PQL on levels of immunal proteins, C3, C4 and expressions of CD4, CD8, and CD25 on lymphocytes of peripherial blood in patients with breast carcinoma undergoing radiotherapy

WANG Chun-gang1,2, JIA Xiao-jing1,3, DONG Li-hua1,3, WU Zhen-feng1,GONG Shou-liang3*, MA Xing-yuan4, CHEN Yan-ping4   

  1. 1. Department of Radiotherapy, Second Hospital, Jilin University, Changchun 130041,China;2. Department of Radiotherapy, No.208 Hospital of PLA, Changchun 130062,China;3. MH Radiobiolgy Reserch Unit,School of Public Health, Jilin University, Changchun 130021,China;4. Department of Teaching Centre,School of Basic Medical Sciences, Jilin University, Changchun 130021,China
  • Received:2002-11-23 Revised:1900-01-01 Online:2005-03-28 Published:2005-03-28
  • Contact: GONG Shou-liang

摘要: 目的:探讨西洋参叶三醇组皂苷(PQL)对乳腺癌放疗患者细胞免疫功能的影响。方法:30 例乳腺癌放疗患者随机分为PQL观察组(17例)和对照组(13例);两组在进行放射治疗的同时,PQL观察组口服PQL,对照组不给该药;放疗40 Gy后取外周血测定白细胞计数,免疫球蛋白IgG、IgA、IgM及补体C3、C4、T淋巴细胞转化率和淋巴细胞CD4、CD8、CD25阳性细胞百分率。 结果:在对照组中,患者的外周血白细胞计数为(4.02±0.67)×109•L-1,淋巴细胞转化率为7 966±1 562,而PQL实验组中分别为(6.17±1.20)×109•L-1,18 035±1 577,明显高于对照组(P<0.001)。在PQL观察组中,CD8及CD25阳性细胞的百分率(%)分别为20.9±5.08和41.3±6.15,与对照组比较差异具有显著性(P<0.05,P<0.001)。两试验组中免疫球蛋白IgG、IgA、IgM及补体C3、C4水平差异无显著性。结论:PQL增强乳腺癌放疗患者的细胞免疫功能。

关键词: 药理学, 皂苷类, 药理学, 人参皂甙类, 药理学, 乳腺肿瘤, 放射疗法, 免疫功能

Abstract: Objective To evaluate the effects of panaxatriol in quinquefolium leaf (PQL) on immune functions in the patients with breast carcinoma undergoing radiotherapy. Methods Thirty patients with breast carcinoma undergoing radiotherapy were randomly divided into 2 groups: panaxatriol treatment group (n=17) and control group (n=13). All patients in panaxatriol treatment group were administrated with PQL as well as radiotherapy, no administration in control group. After radiotherapy with 40 Gy, the white cells count and IgG, IgA, IgM, C3, and C4 values, and the percentages of CD4+, CD8+, CD25+ and lymphocyte transformation rate of peripheral blood in the patients were examined. Results There were (4.02±0.67)×109•L-1 and (6.17±1.20)×109•L-1 white blood cells,respectively, in control and PQL groups. The lymphocyte transformation rate of peripheral blood were 7 966±1 562 in the control group, while 18 035±1 577 in PQL group, which was significantly higher than that in control group(P<0.001). The percentages of CD8+ and CD25+ T lymphocytes in PQL group were significantly higher than those in control group (P<0.05, P<0.001). Conclusion The PQL could enhance the cellular immune function in patients with breast carcinoma undergoing radiotherapy.

Key words: Saponins, pharmacology, breast neoplasms, radiotherapy, immune function

中图分类号: 

  • R730.5